In a nutshell This review assessed the effectiveness and safety of ultra-rapid insulin analogs (URIAs) with continuous subcutaneous insulin systems (CSII) in adults with type 1 diabetes (T1D). The authors concluded that URIAs were compatible with CSII systems and had a better glucose-lowering effect after meals compared to rapid-acting insulin...
Read MoreIn a nutshell This study wanted to find out if people with type 1 diabetes who use insulin pumps have fewer changes in their blood glucose control than those who use multiple daily injections. The study found that the patients who used insulin pumps had fewer changes in blood glucose control than those on multiple daily...
Read MoreDaily insulin therapy is needed to maintain normal blood sugar levels (“glycemic control”) in all patients with type 1 diabetes mellitus (T1DM) and many patients with type 2 diabetes mellitus (T2DM). Insulin is usually given using insulin “pens” or insulin pumps. Glycemic control is assessed by frequent self-monitoring glucose...
Read More
In a nutshell This study compared hybrid closed-loop (HCL) insulin delivery to an insulin pump or daily injections for adults with type 1 diabetes (T1D). It found that an HCL system led to better glucose control and a more positive experience of managing diabetes. Some background For many patients with T1D, managing blood glucose (sugar) levels is a...
Read More
In a nutshell This study examined which controlled blood glucose levels better in patients with type 1 diabetes (T1D) partaking in exercise – insulin pumps or a combination of insulin pumps and long-acting injections. The authors found that the combination was more effective for these patients. Some background Exercise has numerous...
Read More
In a nutshell This study compared two methods of monitoring blood glucose and administering insulin to see which was most effective for patients with type 1 diabetes (T1D). The authors found that a continuous glucose monitor paired with an insulin pump was more effective at controlling blood glucose levels. Some background Patients with T1D...
Read More
In a nutshell This study compared the effectiveness and safety of a closed-loop and sensor-augmented insulin pumps for patients with Type 1 diabetes (T1D). The authors found that the closed-loop device was more effective but had more side effects for these patients. Some background The main goal of treatment for T1D is to balance blood glucose...
Read More
In a nutshell This study evaluated whether the ‘suspend-before-low’ feature of automatic insulin pumps prevented hypoglycemia (HG) in patients with Type 1 diabetes (T1D). The authors concluded that this feature successfully reduced the rate of HG and was not associated with increased side effects. Some background The goal of...
Read More
In a nutshell The aim of this study was to investigate if reducing basal insulin rate (BRR) 90-minutes before exercise was better at preventing hypoglycemia (dangerously low blood glucose) than suspending the insulin pump (pump suspension; PS) in type 1 diabetes (T1D). The main finding was that BRR 90-minutes before exercise improved blood glucose...
Read More
In a nutshell The aim of this study was to investigate the safety and effectiveness of a closed-loop insulin delivery system for day and night use in patients with type 1 diabetes (T1D). The main finding of the study was that this system was safe and had better blood glucose control than the sensor-augmented pump. Some background Insulin therapy is...
Read More
In a nutshell This study compared the effectivess of an insulin pump with multiple daily injections in patients with type 1 diabetes during pregnancy. The study found that women who used MDI had better blood sugar control and lower blood pressure. Some background Women with type 1 diabetes are able to have babies very safely, as long as their blood...
Read More
In a nutshell This study aimed to see if a closed-loop insulin delivery system (an automatic insulin delivery system) could control blood sugar levels better than the traditional patient-controlled insulin pump in patients with type 1 diabetes (T1D). The main finding was that the closed-loop insulin delivery system improved blood sugar...
Read More
